Project description
Incision-free treatment of pelvic organ prolapse
Pelvic organ prolapse (POP) is a medical condition that occurs when the muscles and tissues that support the pelvic organs (uterus, bladder, rectum) become weakened or damaged, leading to the shift of pelvic organs into the vaginal canal. Despite the high prevalence of POP, the only means of treatment is surgical intervention which is associated with prolonged recovery and pain. Funded by the European Innovation Council, the apyx project aims to promote a medical device for the non-surgical treatment of early-stage POP. The device assists the anchoring of sutures to the ligaments of the pelvic floor without incisions, under local anaesthetic within only 20 minutes.
Objective
Pelvic Organ Prolapse (POP) affects nearly 50% of women over 40 years old globally. 89% of the cases seek treatment for symptomatic early stage prolapse. Despite the high prevalence and the progression of POP over time, patients currently cannot be offered a repair solution until the condition worsens enough for surgical intervention. However, the surgical interventions of prolapse have several side effects like prolonged recovery, pelvic pain and relapses of POP. Escala Medical has developed a minimally invasive and incision-free repair intervention for early-stage POP repair - Apyx. Apyx is the first medical device for treating early stage prolapse, regaining quality of life and prevention of prolapse deterioration for the vast majority, currently un-addressed, POP sufferers. The EIC project will finalize the development of Apyx, conduct clinical trials, and support scale-up and commercialization activities.
Fields of science
Not validated
Not validated
Programme(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Funding Scheme
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended FinanceCoordinator
2017400 MISGRAV
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.